Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.15
Bid: 17.80
Ask: 18.50
Change: -0.30 (-1.63%)
Spread: 0.70 (3.933%)
Open: 18.45
High: 0.00
Low: 0.00
Prev. Close: 18.45
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

13 Sep 2010 07:00

RNS Number : 5190S
BATM Advanced Communications Ld
13 September 2010
 



13 September 2010

 

BATM Advanced Communications Limited

Interim Management Statement

BATM Advanced Communications Limited ("BATM" or the "Company") (LSE: BVC), a leading designer and producer of broadband data and telecoms systems and medical laboratory systems, is today issuing its Interim Management Statement for the period from 1 July 2010 to 31 August 2010.

Current trading update 

Total revenues in the first two months of the second half of 2010 were $ 18.6 million, compared with $19.1 million in the equivalent period in 2009. Revenues for the period are broadly inline with those of the equivalent period in 2009 and also with management's expectations.

During these two months the sales mix was 68% from the Telecoms division and 32% from the Medical division as compared to 75% and 25% in the second half of 2009 and 65% and 35% in the first half of 2010.

The gross margin has slightly increased during the first two months of the second half of 2010 over the first half of 2010.

 

Financial position 

The Company's balance sheet remains very strong and at the end of August the effective cash balance stood at $53.4 million, a decrease of $9.4 million compared to the position at 30 June 2010, largely due to the Dividend payment in July amounted to $8.8 million and a slightly increase in inventory balances. 

Outlook Despite the decline of revenues from OEM sales, substantial orders have been received from Tier 1 customers in the US and higher demand for backhaul bandwidth, believed to be mainly due to the introduction of the Iphone4. BATM expects this demand to continue and is ramping up production so deliveries could be accelerated in Q4.

The medical division continues to make progress as was observed in H1 results. Field trials that started with the ISS (Electronically controlled Medical waste disposal) show very good results with orders received for units even before trials are completed. Management remains confident it will achieve its forecasts for the full year 2010 as published in our H1 report.

BATM will conduct a detailed investors and analysts meeting in London on 13 September giving details of its strategy and sales prospects for the years 2011-2013. Presentation materials have been posted in the Investors section of the BATM website.

 

- ends -

 

Enquiries

 

BATM Advanced Communications +972 9866 2525

Dr Zvi Marom, Chief Executive

Threadneedle Communications 020 7653 9850

Josh Royston / Graham Herring

Singer Capital Markets Ltd 020 3205 7626 

Shaun Dobson

Shore Capital 020 7408 4090 

Pascal Keane

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDCRDBBGGG
Date   Source Headline
14th Apr 20229:30 amRNSAnnual Financial Report
13th Apr 20227:00 amRNSAppointment of Non-Executive Director
4th Apr 20227:00 amRNSTransaction in Own Shares and TVR
18th Mar 20227:00 amRNSStrategic Partnership for Edgility with NEXCOM
17th Mar 202210:30 amRNSResult of General Meeting
10th Mar 202212:30 pmRNSHolding(s) in Company
8th Mar 202211:30 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSFull Year Results
23rd Feb 20227:00 amRNSNotice of General Meeting
21st Feb 20227:00 amRNSStrategic Partnership for Edgility with Advantech
17th Feb 20227:00 amRNSTrading Update and Notice of Results
3rd Feb 202211:23 amRNSClarification on FTSE Nationality Review
3rd Feb 20227:00 amRNSUpdate on FTSE Nationality Review & Share Buyback
31st Jan 20227:00 amRNSUpdate on Ador Diagnostics
17th Jan 20227:00 amRNSUpdate on FTSE Nationality Review
4th Jan 20227:00 amRNSDividend Declaration
4th Jan 20227:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSFirst sales of rapid COVID-19 test in Russia
14th Dec 202111:45 amRNSResult of AGM and Dividend Declaration
30th Nov 20217:00 amRNSCOVID-19 tests effective in diagnosing Omicron
25th Nov 20213:00 pmRNSBlock Listing Interim Review
22nd Nov 20213:00 pmRNSNotice of AGM and Dividend Declaration
10th Nov 20217:00 amRNSBATM receives $3.5m cyber security contract
3rd Nov 20217:00 amRNSNew five-year contract for Edgility
1st Nov 20217:00 amRNSBATM receives agri-waste contract in Botswana
7th Oct 20217:00 amRNSStrategic partnership for NFV with AudioCodes
13th Sep 20217:00 amRNSFirst enterprise customer for NFV with $2m order
23rd Aug 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSNotice of Results
12th Jul 20217:00 amRNSLaunch of Edgility networking NFV-based ecosystem
5th Jul 20217:00 amRNSBATM receives $10m cyber security contract
15th Jun 20217:00 amRNSBATM receives $4.1m cyber security contract
26th May 20217:00 amRNSBlock listing Interim Review
18th May 20217:00 amRNSBATM commences delivery of new COVID-19 tests
19th Apr 202110:25 amRNSAnnual Financial Report
12th Apr 20217:00 amRNSStrategic partnership for NFV
29th Mar 20217:00 amRNSBATM develops molecular diagnostics test for TB
19th Mar 20217:00 amRNSCompletion of Sale of NGSoft
11th Mar 20217:00 amRNSBATM launches no-swab saliva-based COVID-19 test
1st Mar 20217:00 amRNSUpdate on Sale of NGSoft
22nd Feb 20217:00 amRNSFull Year Results
11th Feb 20215:38 pmRNSFTSE Nationality Review
1st Feb 20217:00 amRNSTrading Update and Notice of Results
19th Jan 20217:00 amRNSBATM's NFVTime now available for the public cloud
12th Jan 20217:00 amRNSBATM enters option agreement to sell NGSoft
24th Dec 20207:00 amRNSCOVID-19 test effective in diagnosing new strain
17th Dec 20203:50 pmRNSResult of AGM
15th Dec 20207:00 amRNSUpdate on Ador Diagnostics
7th Dec 20207:00 amRNSDelivery of First Insect Protein Recovery Facility
30th Nov 20203:03 pmRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.